Depreciation of Compass Therapeutics, Inc. from 30 Jun 2020 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Compass Therapeutics, Inc. quarterly and annual Depreciation in USD history and change rate from 30 Jun 2020 to 31 Mar 2025.
  • Compass Therapeutics, Inc. Depreciation for the quarter ending 31 Mar 2025 was $100,000, a 50% decline year-over-year.
  • Compass Therapeutics, Inc. annual Depreciation for 2024 was $600,000, a 14% decline from 2023.
  • Compass Therapeutics, Inc. annual Depreciation for 2023 was $700,000, a 12% decline from 2022.
  • Compass Therapeutics, Inc. annual Depreciation for 2022 was $800,000, a 33% increase from 2021.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Compass Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $100,000 -$100,000 -50% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q1 2024 $200,000 $0 0% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q1 2023 $200,000 $0 0% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q3 2022 $200,000 +$100,000 +100% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q1 2022 $600,000 $200,000 $0 0% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q4 2021 $600,000 $200,000 01 Oct 2021 31 Dec 2021 10-K 15 Mar 2023 2022 FY
Q3 2021 $100,000 -$300,000 -75% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022 2022 Q3
Q2 2021 $100,000 -$300,000 -75% 01 Apr 2021 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 $200,000 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q3 2020 $400,000 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021 2021 Q3
Q2 2020 $400,000 01 Apr 2020 30 Jun 2020 10-Q 16 Aug 2021 2021 Q2

Compass Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $600,000 -$100,000 -14% 01 Jan 2024 31 Dec 2024 10-K 27 Feb 2025 2024 FY
2023 $700,000 -$100,000 -12% 01 Jan 2023 31 Dec 2023 10-K 27 Feb 2025 2024 FY
2022 $800,000 +$200,000 +33% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024 2023 FY
2021 $600,000 01 Jan 2021 31 Dec 2021 10-K 15 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.